RS174562 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Sterol ester (27:1/20:4) levels | G | OR: 0.66 | 1E-365 | PubMed |
| Triglyceride levels | G | β: 0.052 | 2E-187 | PubMed |
| Serum metabolite levels | A | OR: 0.64 | 2E-149 | PubMed |
| Phosphatidylcholine (18:1_18:2) levels | G | OR: 0.4 | 3E-68 | PubMed |
| Phosphatidylcholine (18:1_18:1) levels | G | OR: 0.35 | 6E-54 | PubMed |
| Phosphatidylcholine (18:2_18:2) levels | G | OR: 0.35 | 1E-52 | PubMed |
| Plasma 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* levels in chronic kidney disease | G | OR: 0.2 | 7E-41 | PubMed |
| Eicosanoid 13(S) HOTrE, Eicosanoid 9(S) HOTrE b levels | — | OR: 0.22 | 3E-36 | PubMed |
| Phosphatidylserine (38:3) levels | G | OR: 0.28 | 7E-36 | PubMed |
| Alkylphosphatidylcholine (O-18:0/18:2) levels | G | OR: 0.28 | 2E-34 | PubMed |
| Phosphatidylserine (38:3) levels | G | OR: 0.27 | 4E-34 | PubMed |
| Phosphatidylcholine (18:2_18:2) levels | G | OR: 0.27 | 8E-33 | PubMed |
| Phosphatidylcholine (18:0_18:2) levels | G | OR: 0.27 | 5E-32 | PubMed |
| Plasma 1,2-dipalmitoyl-GPC (16:0/16:0) levels in chronic kidney disease | G | β: 0.058 | 4E-26 | PubMed |
| Plasma 1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)* levels in chronic kidney disease | G | β: 0.097 | 7E-26 | PubMed |
| Phosphatidylcholine (18:1_18:1) levels | G | OR: 0.23 | 1E-23 | PubMed |
| Lysophosphatidylcholine (18:0) [sn1] levels | G | OR: 0.23 | 3E-23 | PubMed |
| Alkylphosphatidylcholine (O-18:1/18:1) levels | G | OR: 0.21 | 9E-20 | PubMed |
| Serum metabolite ratios in chronic kidney disease | G | OR: 0.4 | 1E-19 | PubMed |
| Metabolite levels (1-linoleoylglycerophosphoinositol; 1-linoleoyl-GPI (18:2)) | G | OR: 0.15 | 4E-18 | PubMed |